Medical Xpress February 4, 2025
Emily Packer, eLife

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new study.

The research, published as a Reviewed Preprint in eLife, is described by the editors as an important and timely study, with the potential to revolutionize personalized cancer treatment strategies by providing a method to predict effective to treat the disease. They say the strength of evidence for the effectiveness of the tool, named “retriever,” is solid.

Developing new cancer treatments is an expensive and time-consuming process. Drug discovery is often aided by to quantify the transcriptional signatures—the changes in gene activity—associated with the disease and match them to the response profiles of cell lines that act as...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Survey / Study, Trends
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Walgreens PE deal back on the table: 5 things to know
Stakeholder Management and Interoperability of Biosimilars
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
Pharma Pulse 2/21/25: RWE in Medical Research and Drug Development, Inhaled Antibody Therapy for RSV & more

Share This Article